The emergence of Retatrutide ZPHC, at a dosage of 120mg, is sparking considerable excitement within the weight loss community. This groundbreaking dual GIP and GLP-1 receptor medication appears to deliver impressive improvements in fat loss compared to previous therapies. Early clinical data have